COVID-19 and management of neuroimmunological disorders

The importance of reported neurological manifestations of coronavirus disease 2019 (COVID-19) is still unclear. Nevertheless, an immediate and ongoing neurological challenge posed by the COVID-19 pandemic is the management of patients who are undergoing immunotherapy for existing neuroimmunological...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartung, Hans-Peter, Aktas, Orhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242886/
https://www.ncbi.nlm.nih.gov/pubmed/32444648
http://dx.doi.org/10.1038/s41582-020-0368-9
_version_ 1783537319764033536
author Hartung, Hans-Peter
Aktas, Orhan
author_facet Hartung, Hans-Peter
Aktas, Orhan
author_sort Hartung, Hans-Peter
collection PubMed
description The importance of reported neurological manifestations of coronavirus disease 2019 (COVID-19) is still unclear. Nevertheless, an immediate and ongoing neurological challenge posed by the COVID-19 pandemic is the management of patients who are undergoing immunotherapy for existing neuroimmunological disease.
format Online
Article
Text
id pubmed-7242886
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72428862020-05-22 COVID-19 and management of neuroimmunological disorders Hartung, Hans-Peter Aktas, Orhan Nat Rev Neurol Comment The importance of reported neurological manifestations of coronavirus disease 2019 (COVID-19) is still unclear. Nevertheless, an immediate and ongoing neurological challenge posed by the COVID-19 pandemic is the management of patients who are undergoing immunotherapy for existing neuroimmunological disease. Nature Publishing Group UK 2020-05-22 2020 /pmc/articles/PMC7242886/ /pubmed/32444648 http://dx.doi.org/10.1038/s41582-020-0368-9 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Hartung, Hans-Peter
Aktas, Orhan
COVID-19 and management of neuroimmunological disorders
title COVID-19 and management of neuroimmunological disorders
title_full COVID-19 and management of neuroimmunological disorders
title_fullStr COVID-19 and management of neuroimmunological disorders
title_full_unstemmed COVID-19 and management of neuroimmunological disorders
title_short COVID-19 and management of neuroimmunological disorders
title_sort covid-19 and management of neuroimmunological disorders
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242886/
https://www.ncbi.nlm.nih.gov/pubmed/32444648
http://dx.doi.org/10.1038/s41582-020-0368-9
work_keys_str_mv AT hartunghanspeter covid19andmanagementofneuroimmunologicaldisorders
AT aktasorhan covid19andmanagementofneuroimmunologicaldisorders

Ejemplares similares